| |AUGUST 20244Vol 2 · Issue 01 - 8 · AUGUST, 2024Publisher Alok ChaturvediEditor Sudhakar SinghAssistant Editor Roshan AktharEditorial Team Viswanathan A Hridkamal Roy Rejith RajanSenior Designer Rajesh R B DesignerAruna kSuanya BanerjeeAdvertising QueriesRahul KumarGM Sales & MarketingRavi kalgisales@indiapharmaoutlook.com Editorial Querieseditor@indiapharmaoutlook.comCirculation Manager Magendran PerumalMagazine Price is Rs. 150 per issuePrinted and Published By Alok Chaturvedi on behalf of Silicon Media Technologies Pvt. Ltd. and Printed at Executive Prints - 113/7, Ground floor, Old madras road, Halasuru, Bangalore 560008 and Published At No. 124, 2nd Floor, Surya Chambers, Old Airport Road, Murugeshpalya, Bangalore-560017.Publisher Alok ChaturvediCopyright © 2024 Silicon Media Technologies Pvt. Ltd., All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher.The market of injectable drugs in India is on the rise with many factors contributing to the promising growth rate. This is because it is occasioned by new diseases, increasing cases of chronic diseases, increased population age, and the need to improve the treatment processes. The movement from disease orientation to biologics and targeted therapies as well as improvement in the drug delivery systems is transforming the injectables market in India. This growth is attributed to the improvement of the healthcare sector in India and the availability of the health facilities. With the increased establishment of hospitals and specialized clinics, there is a higher demand for injectable products particularly for diabetes, cancer, and autoimmune diseases. Furthermore, the government's awareness of the need to promote the healthcare standards and its initiatives are driving this sector forward. The other factor is the growth in the density of health concern and the emerging pattern of using injectable products for self-treatment. This is because of advancements in the systems of drug delivery such as the pre-filled syringes and auto-injectors which are more efficient. Further, the research and development units of the Indian pharmaceuticals are also improving the development of new injectable drugs. India is not only meeting the domestic demand but exporting biosimilars and novel biologics as it has a good pipeline of products.Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies from this sector that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market's evolution through their innovative disposition, these firms are blazing a trail. We look forward to receiving your feedback and suggestions. Sudhakar SinghEditoreditor@indiapharmaoutlook.comEmpowering Wellness through Injectables
< Page 3 | Page 5 >